Concepedia

Thomas Appl

TA

Statistics

Publications

7

Citations

329

H-Index

7

Active since

2004

Affiliations

Charité - Universitätsmedizin Berlin(Current)

German Red Cross

Technische Universität Dresden

Humboldt-Universität zu Berlin

Universität Ulm

Thomas Appl is an author at Charité - Universitätsmedizin Berlin specializing in life sciences, convalescent plasma therapy, and clinical immunology.

Publications per year

2004–2022

7

Publications

7

Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19

Sixten Körper, Daniel Zickler, Thomas Wiesmann et al. · Journal of Clinical Investigation · 2021 · 89 citations · Full text

, , +12

Inhibition of glutaminyl cyclase prevents pGlu‐Aβ formation after intracortical/hippocampal microinjection <i>in vivo</i>/<i>in situ</i>

Stephan Schilling, Thomas Appl, Torsten Hoffmann et al. · Journal of Neurochemistry · 2008 · 74 citations

, , +17

40th EASD Annual Meeting of the European Association for the Study of Diabetes

M. Veitenhansl, K. Stegner, F. X. Hierl et al. · Diabetologia · 2004 · 68 citations · Full text

, , +11

Spontaneous <i>In Vitro</i> Transformation of Adult Neural Precursors into Stem‐Like Cancer Cells

Florian A. Siebzehnrübl, Ina Jeske, Dorit Müller et al. · Brain Pathology · 2008 · 36 citations · Full text

, , +17

Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies

Sixten Körper, Bernd Jahrsdörfer, Victor M. Corman et al. · Transfusion Medicine and Hemotherapy · 2021 · 25 citations · Full text

, , +17

1–5 of 7